294
Participants
Start Date
August 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
May 31, 2018
Therapy ON
Intermittent, programmable, intra-abdominal vagal blocking device that delivers therapy (Therapy ON)
Therapy OFF
Active intra-abdominal placebo device that delivers no therapy (Therapy OFF)
Institute of Weight Control, Sydney
Adelaide Bariatric Center - Flinders Private Hospital, Bedford Park
Johns Hopkins, Baltimore
Virginia Commonwealth University, Richmond
Cleveland Clinic - Florida, Weston
Cleveland Clinic - Ohio, Cleveland
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Washington University School of Medicine, St Louis
HonorHealth (formerly Scottsdale Bariatric Center), Scottsdale
Scripps Clinic, La Jolla
University of California, Irvine Medical Center, Orange
Stanford University Medical Center, Stanford
Tufts New England Medical Center, Boston
Oregon Health & Science University, Portland
Lead Sponsor
ReShape Lifesciences
INDUSTRY